Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2008The Oncologist

High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDaniele SantiniUniversité Claude Bernard Lyon 1FLFotios LoupakisUniversity of PisaBVBruno VincenziUniversità Cattolica del Sacro Cuore

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santini et al. (2008) studied this question.

synapsesocial.com/papers/6a6be7ca01245da06ecba30bhttps://doi.org/10.1634/theoncologist.2008-0181
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer2008 · 3,217 citations
  2. 2KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab2008 · 1,459 citations
  3. 3Genetic Alterations during Colorectal-Tumor Development1988 · 6,784 citations
  4. 4Different Genetic Features Associated with Colon and Rectal Carcinogenesis2004 · 229 citations
  5. 5Monoclonal antibodies to target epidermal growth factor receptor–positive tumors2002 · 449 citations